Goldman Sachs Group Inc Astrazeneca PLC Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 11,781,848 shares of AZN stock, worth $824 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
11,781,848
Previous 13,647,948
13.67%
Holding current value
$824 Million
Previous $1 Billion
13.67%
% of portfolio
0.15%
Previous 0.17%
Shares
22 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.23 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...